MedTrace Logo

Postoperative Pain After Caesarian Section

NCT05659823 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2023-04-18

No results posted yet for this study

Summary

To examine if perioperative pain/nausea/pruritus is altered when current standard analgesia for caesarian section (CS) is replaced with new guideline recommended analgesia.

Conditions

  • Pain, Postoperative
  • Pruritus
  • Nausea and Vomiting Following Administration of Anaesthetic Agent
  • Consumption

Interventions

DRUG

Bupivacaine-fentanyl-morphine elective group

Guideline recommended analgesia in elective caesarian section.

DRUG

Bupivacaine-fentanyl elective group

Current analgesia in elective caesarian section.

DRUG

Bupivacaine-fentanyl emergency group

Current analgesia in emergency caesarian section.

Sponsors & Collaborators

  • Conrad Arnfinn Bjørshol

    lead OTHER_GOV

Principal Investigators

  • Conrad A Bjørshol, PhD, MD · Helse Stavanger HF

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-02
Primary Completion
2021-11-05
Completion
2021-11-05

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05659823 on ClinicalTrials.gov